- Q4 2023 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 07, 2024€24.4 (+5.17%)Earnings
- EyePoint Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- EyePoint Pharmaceuticals Inc Conference call to discuss topline results TranscriptDec 04, 2023
- EyePoint Pharmaceuticals Inc to Host Virtual Key Opinion Leader TranscriptNov 09, 2023
- Q3 2023 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 01, 2023€5.6 (+0.90%)Earnings
- EyePoint Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- EyePoint Pharmaceuticals Inc at HC Wainwright Ophthalmology Virtual Conference - Panel Discussion TranscriptAug 16, 2023
- EyePoint Pharmaceuticals Inc at HC Wainwright Ophthalmology Virtual Conference - On-demand TranscriptAug 16, 2023
- Q2 2023 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 02, 2023€10.9 (-2.68%)Earnings
- EyePoint Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2023€5.8 (-3.33%)Earnings
- EyePoint Pharmaceuticals Inc at Guggenheim Healthy Altitudes Summit TranscriptMar 15, 2023
- Q4 2022 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 02, 2023€2.9 (-7.05%)Earnings
- Q3 2022 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2022€5.5 (+0.92%)Earnings
- Q2 2022 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2022€9.05 (+4.02%)Earnings
- EyePoint Pharmaceuticals Inc Investor Day TranscriptJul 18, 2022
- Q1 2022 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2022€11.2 (-0.88%)Earnings
- EyePoint Pharmaceuticals Inc at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 28, 2022
- Q4 2021 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 03, 2022€8.75 (-3.31%)Earnings
- EyePoint Pharmaceuticals Inc Phase 1 DAVIO Trial Of EYP-1901 Results Conference Call TranscriptNov 13, 2021
- Q3 2021 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2021€10.6 (+1.92%)Earnings
- EyePoint Pharmaceuticals Inc at Benzinga Healthcare Small Cap Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2021€7.1 (+2.16%)Earnings
- Q1 2021 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021€8.7 (-1.14%)Earnings
- Q4 2020 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 04, 2021€9.6 (-4.00%)Earnings
- EyePoint Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- EyePoint Pharmaceuticals Inc to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD TranscriptDec 04, 2020
- Q3 2020 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020€3.8 (+23.38%)Earnings
- Q2 2020 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2020€6.06 (-0.98%)Earnings
- Q1 2020 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020€8.1 (-6.36%)Earnings
- Q4 2019 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 05, 2020€13.1 (-25.14%)Earnings
- Q3 2019 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2019€16 (-22.33%)Earnings
- Q2 2019 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 07, 2019€11.03 (+1.75%)Earnings
- Q1 2019 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2019€14.53 (-2.22%)Earnings
- EyePoint Pharmaceuticals Inc Six-Month Transition Period Ended December 31, 2018 Earnings Call TranscriptMar 14, 2019€22.5 (-1.75%)Earnings
EyePoint Pharmaceuticals Inc at B Riley Neuro & Ophthalmology Conference (Virtual) Transcript
Good morning. Welcome back, everyone, to day two of B. Riley Neuro and Ophthalmology Conference. We thank you all for being part of our conference. And it's my great pleasure to introduce our next presenting company, EyePoint Pharmaceuticals.
Here with me, Jay Duker, the Chief Operating Officer. Thanks, Jay, for being part of this event. Maybe we can kick off our discussion by you giving us an overview of EyePoint.
Obviously, a big transformational year for you guys in the past 12 to 18 months. Would maybe love to hear about the platform that got this going. And then also to see the excitement around the wet AMD program, which we can dive deeper.
Sure. Well, thank you very much for the kind invitation. So EyePoint actually has been a publicly traded company for over 20 years. And its initial product was based on the current sustained-release technology that we call Durasert. It was an implant for CMV retinitis in HIV positive patients. And,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)